• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病患者大脑和脑脊液中tau蛋白和泛素水平升高。

Elevated levels of tau and ubiquitin in brain and cerebrospinal fluid in Alzheimer's disease.

作者信息

Iqbal K, Grundke-Iqbal I

机构信息

New York State Institute for Basic Research in Developmental Disabilities, Staten Island 10314, USA.

出版信息

Int Psychogeriatr. 1997;9 Suppl 1:289-96; discussion 317-21. doi: 10.1017/s1041610297005024.

DOI:10.1017/s1041610297005024
PMID:9447449
Abstract

Alzheimer's disease (AD) is histopathologically characterized by the presence of numerous neurons with neurofibrillary tangles of paired helical filaments (PHF) in the neocortex, particularly the hippocampus. The major protein subunit of PHF, which also accumulate as neuropil threads and dystrophic neurites of the neuritic (senile) plaques, is the microtubule-associated protein tau. tau in AD brain is abnormally hyperphosphorylated. In addition to hyperphosphorylation, some of the AD tau is also ubiquitinated. The level of tau in AD brain is elevated severalfold, and this increase is in the form of the abnormally phospholylated tau. The levels of conjugated ubiquitin are also increased severalfold in AD brain. The cerebrospinal fluid (CSF) levels of both tau and ubiquitin are elevated in AD. However, some of the normal elderly and non-AD neurological control cases also show elevated levels of these two proteins in the CSF. At present, it is not clear whether the overlap in CSF tau or ubiquitin values between AD and the control groups is due to some unknown heterogeneity of AD, inclusion of presymptomatic AD cases in the control group, or lack of specificity of the CSF elevation of these markers to AD. Thus, until the results of prospective studies on many patients with AD and normal controls become available, the CSF tau and ubiquitin levels can be used only as additional tools in the psychometric and clinical diagnosis of AD.

摘要

阿尔茨海默病(AD)的组织病理学特征是新皮质,尤其是海马体中存在大量带有成对螺旋丝(PHF)神经原纤维缠结的神经元。PHF的主要蛋白质亚基也是神经毡丝和神经炎性(老年)斑的营养不良性神经突中积累的物质,即微管相关蛋白tau。AD大脑中的tau异常过度磷酸化。除了过度磷酸化外,一些AD tau还被泛素化。AD大脑中tau的水平升高了几倍,这种增加是以异常磷酸化的tau形式存在的。AD大脑中结合泛素的水平也增加了几倍。AD患者脑脊液(CSF)中tau和泛素的水平均升高。然而,一些正常老年人和非AD神经对照病例的脑脊液中这两种蛋白质的水平也升高。目前尚不清楚AD与对照组脑脊液tau或泛素值的重叠是由于AD某些未知的异质性、对照组中纳入了症状前AD病例,还是这些标志物脑脊液升高对AD缺乏特异性。因此,在获得许多AD患者和正常对照的前瞻性研究结果之前,脑脊液tau和泛素水平只能作为AD心理测量和临床诊断的辅助工具。

相似文献

1
Elevated levels of tau and ubiquitin in brain and cerebrospinal fluid in Alzheimer's disease.阿尔茨海默病患者大脑和脑脊液中tau蛋白和泛素水平升高。
Int Psychogeriatr. 1997;9 Suppl 1:289-96; discussion 317-21. doi: 10.1017/s1041610297005024.
2
Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles.神经原纤维变性及神经原纤维缠结形成的机制。
J Neural Transm Suppl. 1998;53:169-80. doi: 10.1007/978-3-7091-6467-9_15.
3
Aluminum modifies the properties of Alzheimer's disease PHF tau proteins in vivo and in vitro.铝在体内和体外均可改变阿尔茨海默病PHF tau蛋白的特性。
J Neurosci. 1994 Nov;14(11 Pt 2):7221-33. doi: 10.1523/JNEUROSCI.14-11-07221.1994.
4
A population-based study of tau protein and ubiquitin in cerebrospinal fluid in 85-year-olds: relation to severity of dementia and cerebral atrophy, but not to the apolipoprotein E4 allele.一项针对85岁老人脑脊液中tau蛋白和泛素的基于人群的研究:与痴呆严重程度和脑萎缩的关系,但与载脂蛋白E4等位基因无关。
Neurodegeneration. 1995 Dec;4(4):433-42. doi: 10.1006/neur.1995.0052.
5
Comparison of the neurofibrillary pathology in Alzheimer's disease and familial presenile dementia with tangles.阿尔茨海默病和伴有缠结的家族性早老性痴呆中神经原纤维病理学的比较。
Acta Neuropathol. 1996 Jul;92(1):42-8. doi: 10.1007/s004010050487.
6
Qualitative and quantitative differences in senile plaque dystrophic neurites of Alzheimer's disease and normal aged brain.阿尔茨海默病与正常老年大脑中淀粉样斑块营养不良性神经突的定性和定量差异。
J Neuropathol Exp Neurol. 1995 Jul;54(4):548-56. doi: 10.1097/00005072-199507000-00009.
7
Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention.阿尔茨海默病神经纤维变性:意义、病因发病机制、治疗与预防
J Cell Mol Med. 2008 Jan-Feb;12(1):38-55. doi: 10.1111/j.1582-4934.2008.00225.x. Epub 2007 Jan 9.
8
Plaque biogenesis in brain aging and Alzheimer's disease. I. Progressive changes in phosphorylation states of paired helical filaments and neurofilaments.脑衰老和阿尔茨海默病中的斑块生物发生。I. 成对螺旋丝和神经丝磷酸化状态的渐进性变化。
Brain Res. 1996 Nov 11;739(1-2):79-87. doi: 10.1016/s0006-8993(96)00811-6.
9
Truncated tau protein as a new marker for Alzheimer's disease.截短的tau蛋白作为阿尔茨海默病的一种新标志物。
Acta Virol. 1994 Jun;38(3):173-89.
10
Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins).人类大脑中神经原纤维病变丰富的区域,其具有结合能力的tau蛋白水平会选择性降低,且异常tau异构体(A68蛋白)会积累。
Lab Invest. 1992 Feb;66(2):212-22.

引用本文的文献

1
Almost 50 Years of Monomeric Extracellular Ubiquitin (eUb).近50年的单体细胞外泛素(eUb)研究
Pharmaceuticals (Basel). 2024 Jan 31;17(2):185. doi: 10.3390/ph17020185.
2
Blood-based biomarkers for Alzheimer's disease.用于阿尔茨海默病的基于血液的生物标志物。
EMBO Mol Med. 2022 Jan 11;14(1):e14408. doi: 10.15252/emmm.202114408. Epub 2021 Dec 3.
3
The Diagnostic Potential of Amyloidogenic Proteins.淀粉样蛋白原性蛋白的诊断潜力。
Int J Mol Sci. 2021 Apr 16;22(8):4128. doi: 10.3390/ijms22084128.
4
The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers.采用 AD 生物标志物 5 阶段开发框架评估淀粉样蛋白和磷酸化 tau 血液生物标志物的验证状态。
Eur J Nucl Med Mol Imaging. 2021 Jul;48(7):2140-2156. doi: 10.1007/s00259-021-05253-y. Epub 2021 Mar 6.
5
Biomarkers for the Early Detection and Progression of Alzheimer's Disease.用于阿尔茨海默病早期检测和病情进展的生物标志物。
Neurotherapeutics. 2017 Jan;14(1):35-53. doi: 10.1007/s13311-016-0481-z.
6
Cerebrospinal Fluid proNGF: A Putative Biomarker for Early Alzheimer's Disease.脑脊液前体神经生长因子:早期阿尔茨海默病的一种潜在生物标志物。
Curr Alzheimer Res. 2016;13(7):800-8. doi: 10.2174/1567205013666160129095649.
7
Mild cognitive impairment: historical development and summary of research.轻度认知障碍:历史发展与研究综述
Dialogues Clin Neurosci. 2004 Dec;6(4):351-67. doi: 10.31887/DCNS.2004.6.4/jgolomb.
8
PUTATIVE CSF PROTEIN BIOMARKER CANDIDATES FOR AMNESTIC MILD COGNITIVE IMPAIRMENT.遗忘型轻度认知障碍的潜在脑脊液蛋白生物标志物候选物
Transl Neurosci. 2010 Mar 1;1(1):2-8. doi: 10.2478/v10134-010-0004-0.
9
cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases.cNEUPRO:神经退行性疾病的新型生物标志物
Int J Alzheimers Dis. 2010 Sep 19;2010:548145. doi: 10.4061/2010/548145.
10
Antioxidant therapy in Alzheimer's disease: theory and practice.阿尔茨海默病的抗氧化治疗:理论与实践
Mini Rev Med Chem. 2008 Nov;8(13):1395-406. doi: 10.2174/138955708786369582.